Background: About 25% of all patients seeking psychotherapeutic treatment are considered to be alexithymic. Alexithymia has been assumed to be negatively associated with therapeutic outcome. On the other hand, it is unclear to which extent alexithymia itself may be modified by psychotherapeutic interventions. Methods: From 414 consecutively admitted inpatients, 297 were followed up after 4 weeks (t1) and after 8–12 weeks (t2) upon discharge. Patients were treated with psychodynamic group therapy in a naturalistic setting. The Toronto Alexithymia Scale (TAS-20) and the Symptom Checklist-90 were administered. Results: Twenty-seven percent of the patients were alexithymic (TAS-20 ≧61) at baseline. Multivariate models with repeated measurements indicated significant changes in Global Severity Index of the Symptom Checklist-90 in both alexithymic and nonalexithymic subjects. However, alexithymic subjects had significantly higher Global Severity Index scores than nonalexithymic subjects at t0, t1 and t2 (p < 0.001). The TAS-20 scores demonstrated a high relative stability in the total sample. However, in the alexithymic group, the TAS-20 scores changed considerably from baseline to discharge [66.3 (SD = 4.7) to 55.9 (SD = 9.9); t = 8.69; d.f. = 79; p < 0.001]. Conclusion: The inpatient treatment program including psychodynamic group therapy significantly reduced psychopathological distress and alexithymic features in alexithymic patients. Still, these patients suffered from higher psychopathological distress at discharge than nonalexithymics. Therefore, alexithymic features may negatively affect the long-term outcome.

Keywords:
Alexithymia, Psychodynamic therapy, Group therapy, Relative stability, Absolute stability
1.
Weissman MM, Prusoff BA, Klerman GL: Personality and the prediction of long-term outcome of depression. Am J Psychiatry 1978;135:797–800.
2.
Sotsky SM, Glass DR, Shea MT, Pilkonis PA, Collins JF, Elkin I, Watkins JT, Imber SD, Leber WR, Moyer J, et al: Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry 1991;148:997–1008.
3.
Grabe HJ, Rainermann S, Spitzer C, Gänsicke M, Freyberger HJ: The relationship between dimensions of alexithymia and dissociation. Psychother Psychosom 2000;69:128–131.
4.
Honkalampi K, Hintikka J, Laukkanen E, Lehtonen J, Viinamaki H: Alexithymia and depression: a prospective study of patients with major depressive disorder. Psychosomatics 2001;42:229–234.
5.
Taylor GJ, Bagby RM, Parker JDA: Disorders of Affect Regulation: Alexithymia in Medical and Psychiatric Illness. Cambridge, Cambridge University Press, 1997.
6.
Honkalampi K, Hintikka J, Saarinen P, Lehtonen J, Viinamaki H: Is alexithymia a permanent feature in depressed patients? Results from a 6-month follow-up study. Psychother Psychosom 2000;69:303–308.
7.
Grabe HJ, Ruhrmann S, Ettelt S, Müller A, Buthz F, Hochrein A, Meyer K, Kraft S, Reck C, Pukrop R, Klosterkötter J, Falkai P, Maier W, Wagner M, Freyberger HJ: Alexithymia in obsessive compulsive disorder – results from a family study. Psychother Psychosom 2006;75:312–318.
8.
Marchesi C, Fonto S, Balista C, Cimmino C, Maggini C: Relationship between alexithymia and panic disorder: a longitudinal study to answer an open question. Psychother Psychosom 2005;74:56–60.
9.
Parker JD, Wood LM, Bond BJ, Shaughnessy P: Alexithymia in young adulthood: a risk factor for pathological gambling. Psychother Psychosom 2005;74:51–55.
10.
Grabe HJ, Spitzer C, Freyberger HJ: The relationship between alexithymia, personality and psychopathology. Am J Psychiatry 2004;161:1299–1301.
11.
Wise, TN, Mann LS, Randell P: The stability of alexithymia in depressed patients. Psychopathology 1995;28:173–176.
12.
Saarijarvi S, Salminen JK, Toikka T: Alexithymia and depression: A 1-year follow-up study in outpatients with major depression. J Psychosom Res 2001;51:729–733.
13.
Fukunishi I, Kikuchi M, Tabuko M: Changes in scores on alexithymia over a period of psychiatric treatment. Psychol Rep 1996;80:483–489.
14.
Luminet O, Bagby RM, Taylor GJ: An evaluation of the absolute and relative stability of alexithymia in patients with major depression. Psychother Psychosom 2001;70:254–260.
15.
Santor DA, Bagby RM, Joffe RT: Evaluating stability and change in personality and depression. J Pers Soc Psychol 1997;73:1354–1362.
16.
Salminen JK, Saarijarvi S, Toikka T, Kauhanen J, Aarela E: Alexithymia behaves as a personality trait over a 5-year period in Finnish general population. J Psychosom Res 2006;61:275–278.
17.
Wise NT, Mann LS, Shay L: Alexithymia and the five-factor model of personality. Compr Psychiatry 1992;33:147–151.
18.
Luminet O, Bagby RM, Wagner H, Taylor GJ, Parker JD: Relation between alexithymia and the five-factor model of personality: a facet-level analysis. J Pers Assess 1999;73:345–358.
19.
Grabe HJ, Spitzer C, Freyberger HJ: Alexithymia and the temperament and character model of personality. Psychother Psychosom 2001;70:261–267.
20.
Saarijärvi S, Salminen JK, Toikka T: Temporal stability of alexithymia over a five-year period in outpatients with major depression. Psychosom Psychother 2006;75:107–112.
21.
Beresnevaite M: Exploring the benefits of group psychotherapy in reducing alexithymia in coronary heart disease patients: a preliminary study. Psychother Psychosom 2000;69:117–122.
22.
Spitzer C, Siebel-Jürges U, Barnow S, Grabe HJ, Freyberger HJ: Alexithymia and interpersonal problems. Psychother Psychosom 2005;74:240–246.
23.
Sifneos PE: Problems of psychotherapy of patients with alexithymic characteristics and physical disease. Psychother Psychosom 1975;26:65–70.
24.
Taylor GJ, Bagby RM: New trends in alexithymia research. Psychother Psychosom 2004;73:68–77.
25.
Bach M, Bach D: Predictive value of alexithymia: a prospective study in somatizing patients. Psychother Psychosom 1995;64:43–48.
26.
Porcelli P, Bagby RM, Taylor GJ, DE Carne M, Leandro G, Todarello O: Alexithymia as predictor of treatment outcome in patients with functional gastrointestinal disorders. Psychosom Med 2003;65:911–918.
27.
McCallum M, Pipere WE, Ogrodniczuk JS, Joyce AS: Relationships among psychological mindedness, alexithymia and outcome in four forms of short-term psychotherapy. Psychol Psychother Theor Res Pract 2003;76:133–144.
28.
Viinamaki H, Hintikka J, Tanskanen A, Honkalampi K, Antikainen R, Koivumaa-Honkanen H, Haatainen K, Saarinen P, Lehtonen J: Partial remission in major depression: a two-phase, 12-month prospective study. Nordic J Psychiatry 2002;56:33–37.
29.
Rufer M, Hand I, Braatz A, Alsleben H, Fricke S, Peter H: Prospective study of alexithymia in obsessive-compulsive patients treated with multimodal cognitive-behavioral therapy. Psychosom Psychother 2004;73:101–106.
30.
Bach M, Bach D, de Zwaan M, Serim M, Böhmer F: Validierung der deutschen Version der 20-Item Toronto-Alexithymie-Skala bei Normalpersonen und psychiatrischen Patienten. Psychother Psychosom Med Psychol 1996;46:23–28.
31.
Bagby RM, Taylor GJ, Parker JD: The Twenty-Item Toronto Alexithymia Scale. I. Item selection and cross-validation of the factor structure. J Psychosom Res 1994;38:23–32.
32.
Bagby RM, Taylor GJ, Parker JD: The Twenty-Item Toronto Alexithymia Scale. II. Convergent, discriminant, and concurrent validity. J Psychosom Res 1994;38:33–40.
33.
Franke GH: SCL-90-R. Die Symptom-Checkliste von Derogatis, ed 2. Weinheim, Beltz, 2002.
34.
Derogatis L: Symptom Checklist-90-R. Baltimore, Clinical Psychometric Research, 1983.
35.
Schauenburg H, Strack M: Measuring psychotherapeutic change with the symptom checklist SCL 90 R. Psychother Psychosom 1999;68:199–206.
36.
Schmitz N, Hartkamp N, Franke GH: Assessing clinically significant change: application to the SCL-90-R. Psychol Rep 2000;86:263–274.
37.
Äärelä E, Saarijärvi S, Salminen JK, Toikka T: Alexithymic features do not predict compliance with psychotherapy in consultation-liaison patients. Gen Hosp Psychiatry 1997;19:229–233.
38.
Graugaard PK, Holgersen K, Finset A: Communicating with alexithymic and non-alexithymic patients: an experimental study of the effect of psychosocial communication and empathy on patient satisfaction. Psychosom Psychother 2004;73:92–100.
39.
Ogrodniczuk JS, Piper WE, Joyce AS: Alexithymia as a predictor of residual symptoms in depressed patients who respond to short-term psychotherapy. Am J Psychother 2004;58:150–161.
40.
Bagby RM, Taylor GJ, Parker JD, Dickens SE: The development of the Toronto Structured Interview for Alexithymia: item selection, factor structure, reliability and concurrent validity. Psychother Psychosom 2006;75:25–39.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.